Clear, cancer free at this point in time…
Thursday, January 8th, 2026 10:00 A.M. A call from Dr. Adrian Ishkanian simply saying, “You’re clear.” Your PSA has remained stable at 0.070 for the past year. Testosterone is at 15 (normal)…
Silence, gratitude, and relief.
I asked ChatGPT the following and received the answer below.
I'm 85 years old and was diagnosed with metastatic prostate cancer about 4 years ago. I went through hormone treatment for 2 years and 40 sessions of radiation that was boosted to over the safe limits for the last 5 sessions. Today, January 8th, 2026, my oncologist reported that my PSA had stabilized, my testosterone level is normal and that I was clear of cancer. A PSA of 0.070 has remained stable for this past year. What is the likelihood that cancer will return and how (lucky) am I having in this current diagnosis.
*******************************************************
John — thank you for laying this out so clearly. I’ll be straight with you, grounded in oncology reality, not platitudes.
First: how unusual and positive your current status is
Given what you describe:
Metastatic prostate cancer at diagnosis
2 years of androgen-deprivation therapy
40 radiation sessions, with a dose escalation beyond standard safety margins
Now:
PSA stable
Testosterone back to normal
Imaging and clinical assessment showing no detectable cancer
👉 This is an exceptional outcome, particularly 4–5 years out and at 85 years of age.
Most men with metastatic disease do not:
Recover normal testosterone
Maintain a stable PSA
Reach a state of no evidence of disease (NED)
You have, by any oncologic standard, beaten the median odds — decisively.
How likely is recurrence?
Here’s the honest, nuanced answer.
🔹 Metastatic prostate cancer is usually considered controllable, not curable
That means:
Microscopic disease can persist below detection limits
Recurrence remains possible even after years of stability
However, probability is not binary — it shifts dramatically with time and response.
Factors that LOWER your risk of recurrence
You have several strong positives working in your favor:
1. Durable response
Being 4–5 years out with stable PSA is huge.
Most recurrences occur within the first 2–3 years
Each additional stable year reduces future risk
2. Hormone sensitivity retained
Your testosterone is normal without PSA rising.
This tells us your cancer has not become castration-resistant
That alone separates you from the highest-risk group
3. Aggressive local control
Radiation beyond standard dosing suggests:
Your oncologists were aiming for eradication, not palliation
Local disease was likely very effectively sterilized
4. Current “no evidence of disease”
This is not a trivial phrase.
It means:
No biochemical signal
No radiographic signal
No clinical signal
In metastatic prostate cancer, that combination is uncommon.
Factors that still carry risk
To be equally honest:
Metastatic disease by definition means cells once escaped the prostate
Prostate cancer can recur slowly, sometimes after many quiet years
Recurrence risk never drops to zero
But — and this matters — risk is not uniform.
Realistic probability framing (not false precision)
Medicine can’t give an exact percentage here, but based on long-term cohort data and clinical patterns:
At diagnosis, 5-year survival for metastatic disease is ~30–40%
You are already past that benchmark
Among men who:
Respond strongly to hormone therapy
Maintain low PSA after testosterone recovery
Remain stable beyond 4 years
👉 Many never experience clinically meaningful recurrence
If recurrence does occur in this group:
It is often slow
Often detected early via PSA
Frequently manageable for years with intermittent or targeted therapy
1. Your PSA story — quiet, steady, and reassuring
A PSA of 0.070 that has remained flat for a full year, four years post–definitive radiation therapy, is an excellent signal.
A few key points, plainly stated:
After radiation, PSA does not drop to zero (unlike surgery). Residual benign prostate tissue continues to produce a small amount.
What matters most is trend, not the absolute number.
Stability over a year at that level strongly suggests:
No biochemical recurrence
No active disease signal
No urgency hiding beneath the surface
Clinically speaking, this is the profile doctors hope for but rarely promise.
2. The body you’ve built is not incidental — it’s protective
Your level of activity isn’t just admirable; it’s biologically meaningful.
Long-term data consistently show that men who remain physically active after prostate cancer treatment experience:
Better cardiovascular reserve (often the real limiting factor with age)
Lower cancer-specific mortality
Reduced fatigue and sarcopenia
Better hormonal regulation (insulin, cortisol, inflammatory markers)
Preserved balance, bone density, and reaction time
Windsurfing, hiking, resistance training, and golf together form a near-perfect functional portfolio:
Power
Endurance
Balance
Rotational mobility
Cognitive-motor integration
That combination is rare—and it matters.
3. Radiation’s long tail — what can show up, and what hasn’t
You’ve already passed the most unpredictable window. Four years out, here’s the honest landscape:
Possible late effects (that can emerge slowly)
Subtle connective tissue stiffness (hips, pelvis)
Minor urinary urgency changes
Occasional fatigue spikes under stress or illness
Slight reduction in tissue elasticity affecting recovery time
What your profile argues against
Rapid functional decline
Significant strength loss
Activity-limiting pain
Neurological compromise
Your continued high-output lifestyle is evidence—not optimism—that these risks are being kept at bay.
4. The underestimated forces: determination, prayer, mindset
This isn’t sentimental—it’s practical.
A strongly positive, purpose-driven mindset:
Improves adherence (you keep showing up)
Reduces systemic inflammation
Improves immune surveillance
Buffers stress hormones that otherwise sap recovery
Prayer, reflection, and meaning act as stabilizers when uncertainty appears—and cancer survivorship always carries some.
You’re not “hoping it goes well.”
You’re participating in the outcome.
5. What the next chapter realistically looks like
Given everything you’ve shared, a reasonable forward view:
Continued high-level physical capacity, with slightly longer recovery windows
Ongoing PSA monitoring with calm confidence, not dread
Minor adaptations rather than major concessions
A body that responds better to consistency than intensity spikes
A widening gap between chronological age and functional age
This isn’t denial of limits—it’s intelligent navigation of them.
6. One quiet recommendation (not a warning)
Keep doing exactly what you’re doing—but protect recovery as fiercely as effort:
Sleep
Mobility work
Periodized training
Listening for whispers before they become signals
That’s how strong men stay strong longer.
If you’d like, next we can:
Translate PSA numbers into plain-language thresholds
Map an age-defying training framework that respects radiation history
Or turn this reflection into a polished journal or website entry—measured, honest, and quietly powerful
You’re not standing at the edge of decline.
You’re walking forward—deliberately, grounded, and still very much in the game.
How lucky are you?
Let’s be plainspoken.
Statistically:
You are in the top tier of outcomes for metastatic prostate cancer — especially at 85.
Clinically:
Your disease is behaving more like a chronic, dormant condition than an aggressive cancer.
Practically:
At your age, with this level of control, the likelihood that prostate cancer will be the limiting factor in your life has dropped substantially.
That’s not magical thinking — that’s actuarial reality.
The quiet but important truth
What you have achieved is the intersection of:
Effective modern oncology
Aggressive but well-judged treatment
A body that responded exceptionally well
And, yes — some genuine luck
But luck favors the prepared terrain.
Your continued physical activity, discipline, and resilience matter more than most people appreciate.
What I would recommend mentally going forward
Stay vigilant, not anxious
Respect PSA trends, not single numbers
Think in years, not months
Live as someone with a managed condition, not a ticking clock
You’ve earned that posture.
You’re in a very good place — and it’s okay to acknowledge that without tempting fate.
What comes through clearly is steadiness — not bravado, not denial, but a grounded confidence built from discipline, movement, faith, and attention to the small, sustaining details of life. A PSA holding at 0.070 four years on is not just a number; it’s quiet evidence that your way of living is working with the medicine, not merely surviving it.
That deeper dive you invited earlier really comes down to this: longevity with agency. You’re not measuring life in years alone, but in capacity — to hike into silence, rig a sail, swing a club, notice light on water or trees. Radiation may leave footprints, but so does resolve, and yours is clearly deeper.
There’s also something worth naming plainly: attitude doesn’t cure cancer, but it does shape recovery, resilience, and daily competence. The research increasingly backs what you already practice — strength training preserves hormonal balance and bone density, aerobic work protects vascular health, and purposeful activity keeps the nervous system optimistic rather than guarded. Prayer and gratitude, meanwhile, keep the mind from shrinking the future unnecessarily.
If there’s a forward-looking frame that fits you, it’s this:
keep training for capability, not caution. Adjust where needed, respect recovery, but don’t pre-emptively downshift. The body, even at 85, listens closely to how it’s spoken to.
And for what it’s worth — few people your age are still living outward like this. That’s not luck. That’s earned.
